Skip to content

Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation

Effect of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Reconstructing Bone Defects.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01207193
Enrollment
6
Registered
2010-09-22
Start date
2009-10-31
Completion date
2011-12-31
Last updated
2011-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Cyst

Keywords

bone cyst bone defect mesenchymal cell

Brief summary

There are two types of bone cysts, unicameral and aneurismal. These cysts happen to anyone, but they are most commonly seen in children and young adults while their bones are still growing. Living with a bone cyst and determining treatment options depend on the type of cyst. Non-surgical treatments for unicameral bone cysts involves repeated X-rays in individuals who do not experience any symptoms. Surgical removal of a unicameral bone cyst is needed if it becomes especially painful, or the area of the bone starts to thin out. The investigators aim to assess the clinical efficacy and side effects of mesenchymal stem cells seeded on bone matrix in repairing bone cyst.

Detailed description

Bone cysts are benign lesions usually discovered in children from age of 5 to 15 years. Treatment options include observation, corticosteroid injection and surgery. Sometimes the risk of surgery is comparable to the likelihood of fracture without treatment. In orthopedic surgery, bone chips , various types of ceramics, natural and synthetized bone mineral hydroxyapatite and tricalcium phosphate, as well as numerous polymers and co-polymers of alfa-hydroxy acids are used to perform as an osteoconductive and rarely osteoinductive factor to help bone formation.Some evidence demonstrated that bone marrow mesenchymal stem cells deposited on the surface of this constructs enhance its osteogenic differentiation. In this study the investigators seeds cultured bone marrow derived mesenchymal stem cells on bone matrix, to evaluate its therapeutic potential in repairing unicameral or aneurysmal bone cyst.This composite is placed in the bone cyst after its curettage during a surgery.Post-operation assessment is done by X-Ray examination and MRI at 1, 2, 6, and 12 months after treatment.

Interventions

BIOLOGICALcell injection

injection of mesenchymal cells to bone cyst defect

Sponsors

Royan Institute
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Bone cyst diagnosed with MRI, CT-scan, or X-Ray * Intact cyst wall with high risk for fracture * Cysts with minimum diameter of 6mm * Diagnostic test performed on cyst fluid * Provided written consent form

Exclusion criteria

* Patients with diagnosis of cancer * Patients enrolled in other clinical trial

Design outcomes

Primary

MeasureTime frameDescription
fulfill bone cyst defect6 monthsDefect of bone due to cyst fulfill after cell transplantation.

Secondary

MeasureTime frameDescription
effect of mesenchymal cell transplantation6 monthsEvaluate effect of mesenchymal cell transplantation to fulfill the defect of bone cyst.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026